Transplantation: The role of RAAS blockade in kidney transplantation.
作者信息
Toto Robert D
机构信息
Division of Nephrology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, 10526 Ravenscroft Drive, Dallas, Texas 75390, USA.
出版信息
Nat Rev Nephrol. 2016 Mar;12(3):129-31. doi: 10.1038/nrneph.2015.201. Epub 2015 Dec 14.
Abstract
摘要
相似文献
1
Transplantation: The role of RAAS blockade in kidney transplantation.移植：肾素-血管紧张素-醛固酮系统阻断在肾移植中的作用
Nat Rev Nephrol. 2016 Mar;12(3):129-31. doi: 10.1038/nrneph.2015.201. Epub 2015 Dec 14.
2
[How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].[我如何通过优化肾素-血管紧张素-醛固酮系统的阻断来进行治疗]
Rev Med Liege. 2008 Apr;63(4):174-81.
3
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.非糖尿病慢性肾脏病患者肾素-血管紧张素-醛固酮系统的三联药物阻断：一项开放标签交叉随机对照试验
Am J Kidney Dis. 2008 Sep;52(3):486-93. doi: 10.1053/j.ajkd.2008.02.297. Epub 2008 Apr 18.
4
Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.使用血管紧张素受体加阿利吉仑对肾移植受者进行肾素-血管紧张素系统双重阻断可降低严重蛋白尿。
Transplant Proc. 2010 Oct;42(8):2883-5. doi: 10.1016/j.transproceed.2010.07.053.
5
Renin-angiotensin-aldosterone system inhibitors lower hemoglobin and hematocrit only in renal transplant recipients with initially higher levels.肾素-血管紧张素-醛固酮系统抑制剂仅降低初始水平较高的肾移植受者的血红蛋白和血细胞比容。
Eur J Intern Med. 2016 Apr;29:98-103. doi: 10.1016/j.ejim.2015.12.014. Epub 2016 Jan 7.
6
Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.血管紧张素转换酶抑制剂或 AT1 受体阻滞剂对肾素-血管紧张素-醛固酮阻断作用对造影剂诱导肾病发生率的影响：来自透析与利尿剂（DVD）试验的事后分析。
Nephrol Dial Transplant. 2010 Mar;25(3):759-64. doi: 10.1093/ndt/gfp582. Epub 2009 Nov 9.
7
Hypertension: renin-angiotensin-aldosterone system alterations.高血压：肾素-血管紧张素-醛固酮系统改变。
Circ Res. 2015 Mar 13;116(6):960-75. doi: 10.1161/CIRCRESAHA.116.303587.
8
Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation.肾移植后应用血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂。
Clin Transplant. 2009 Dec;23 Suppl 21:33-6. doi: 10.1111/j.1399-0012.2009.01107.x.
9
Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions.肾素-血管紧张素-醛固酮系统阻断在肾脏保护中的作用：现有证据与未来方向。
J Nephrol. 2012 Nov-Dec;25(6):900-10. doi: 10.5301/jn.5000134.
10
Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.（老年）慢性肾病患者同时进行肾素-血管紧张素-醛固酮阻断治疗在美国住院患者急性肾衰竭流行中起作用吗？——威斯康星州西北部肾病诊疗实践中遇到的三例严重急性肾衰竭病例
Hemodial Int. 2009 Oct;13 Suppl 1:S24-9. doi: 10.1111/j.1542-4758.2009.00416.x.
引用本文的文献
1
Kidney disease in non-kidney solid organ transplantation.非肾脏实体器官移植中的肾脏疾病
World J Transplant. 2022 Aug 18;12(8):231-249. doi: 10.5500/wjt.v12.i8.231.
2
Renin-Angiotensin-Aldosterone System and Immunomodulation: A State-of-the-Art Review.肾素-血管紧张素-醛固酮系统与免疫调节：最新综述。
Cells. 2021 Jul 13;10(7):1767. doi: 10.3390/cells10071767.
3
Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation.肾移植后肾内肾素-血管紧张素系统失调。
Sci Rep. 2019 Jul 5;9(1):9762. doi: 10.1038/s41598-019-46114-x.
4
Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.肾移植后的肾功能、蛋白尿与心血管事件风险
Transplant Direct. 2018 Sep 6;4(10):e389. doi: 10.1097/TXD.0000000000000828. eCollection 2018 Oct.
5
Molecular remodeling of the renin-angiotensin system after kidney transplantation.肾移植后肾素-血管紧张素系统的分子重塑
J Renin Angiotensin Aldosterone Syst. 2017 Apr-Jun;18(2):1470320317705232. doi: 10.1177/1470320317705232.
6
Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.肾移植中肾素-血管紧张素系统抑制剂：效益-风险评估
J Nephrol. 2017 Apr;30(2):155-157. doi: 10.1007/s40620-017-0378-x. Epub 2017 Feb 17.
7
The Effect of Renin-angiotensin System Inhibitors on Kidney Allograft Survival: A Systematic Review and Meta-analysis.肾素-血管紧张素系统抑制剂对肾移植存活的影响：一项系统评价与荟萃分析。
N Am J Med Sci. 2016 Jul;8(7):291-6. doi: 10.4103/1947-2714.187141.
本文引用的文献
1
Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.雷米普利与安慰剂治疗蛋白尿肾移植患者的多中心、双盲、随机对照试验。
Lancet Diabetes Endocrinol. 2016 Apr;4(4):318-26. doi: 10.1016/S2213-8587(15)00368-X. Epub 2015 Oct 23.
2
Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts.钙调神经磷酸酶抑制导致肾集合管局部肾素上调及随后血管内皮生长因子的产生。
Transplantation. 2016 Feb;100(2):325-333. doi: 10.1097/TP.0000000000000961.
3
Hypertension, living kidney donors, and transplantation: where are we today?高血压、活体肾供体与移植：我们如今处于什么状况？
Adv Chronic Kidney Dis. 2015 Mar;22(2):154-64. doi: 10.1053/j.ackd.2015.01.002.
4
Angiotensin II blockade in kidney transplant recipients.血管紧张素 II 阻断在肾移植受者中的应用。
J Am Soc Nephrol. 2013 Feb;24(2):320-7. doi: 10.1681/ASN.2012080777. Epub 2013 Jan 10.
5
Kidney graft survival in Europe and the United States: strikingly different long-term outcomes.欧洲和美国的肾脏移植存活率：截然不同的长期结果。
Transplantation. 2013 Jan 27;95(2):267-74. doi: 10.1097/TP.0b013e3182708ea8.
6
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.坎地沙坦可改善肾移植受者的血压控制并减少蛋白尿：来自 SECRET 的结果。
Nephrol Dial Transplant. 2010 Mar;25(3):967-76. doi: 10.1093/ndt/gfp581. Epub 2009 Nov 3.
7
Early use of renin-angiotensin-aldosterone system inhibitors after renal transplantation.肾移植后早期使用肾素-血管紧张素-醛固酮系统抑制剂
Nat Clin Pract Nephrol. 2008 Jun;4(6):306-7. doi: 10.1038/ncpneph0808. Epub 2008 Apr 29.
8
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.肾移植后，使用血管紧张素转换酶抑制剂或血管紧张素II 1型受体拮抗剂治疗可延长患者生存期并提高移植物存活率。
J Am Soc Nephrol. 2006 Mar;17(3):889-99. doi: 10.1681/ASN.2005090955. Epub 2006 Feb 15.
9
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.血管紧张素受体拮抗剂厄贝沙坦对2型糖尿病肾病患者的肾脏保护作用。
N Engl J Med. 2001 Sep 20;345(12):851-60. doi: 10.1056/NEJMoa011303.
10
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.血管紧张素转换酶抑制对糖尿病肾病的影响。协作研究组。
N Engl J Med. 1993 Nov 11;329(20):1456-62. doi: 10.1056/NEJM199311113292004.
Zotero 插件